| Age group |
|
| 0.016 |
| 15 - 25 | 95 (27.1%) | 15 (23.4%) |
|
| 26 - 35 | 90 (25.6%) | 12 (18.8%) |
|
| 36 - 45 | 74 (21.1%) | 8 (12.5%) |
|
| 46 - 55 | 24 (6.8%) | 11 (17.2%) |
|
| 55+ | 68 (19.4%) | 18 (28.1%) |
|
| BMI |
|
| 0.646 |
| Mean (SD) | 25.87 (4.52) | 25.22 (4.64) |
|
| Median (Q1, Q3) | 25.40 (22.55, 29.20) | 24.50 (21.90, 27.80) |
|
| Min - Max | 17.60 - 37.20 | 19.30 - 32.80 |
|
| Cardiovascular disease |
|
| 0.271 |
| no | 300 (85.5%) | 58 (90.6%) |
|
| yes | 51 (14.5%) | 6 (9.4%) |
|
| Lung disease |
|
| 0.103 |
| no | 339 (96.6%) | 59 (92.2%) |
|
| yes | 12 (3.4%) | 5 (7.8%) |
|
| Kidney disease |
|
| 0.019 |
| no | 351 (100.0%) | 63 (98.4%) |
|
| yes | 0 (0.0%) | 1 (1.6%) |
|
| Neurological disease |
|
| 0.391 |
| no | 347 (98.9%) | 64 (100.0%) |
|
| yes | 4 (1.1%) | 0 (0.0%) |
|
| Immobility |
|
| 0.391 |
| no | 347 (98.9%) | 64 (100.0%) |
|
| yes | 4 (1.1%) | 0 (0.0%) |
|
| Cancer |
|
| 0.175 |
| no | 350 (99.7%) | 63 (98.4%) |
|
| yes | 1 (0.3%) | 1 (1.6%) |
|
| Diabetes type 2 |
|
| 0.568 |
| no | 344 (98.0%) | 62 (96.9%) |
|
| yes | 7 (2.0%) | 2 (3.1%) |
|
| Other diseases |
|
| 0.968 |
| no | 312 (88.9%) | 57 (89.1%) |
|
| yes | 39 (11.1%) | 7 (10.9%) |
|
| ASA score |
|
| < 0.001 |
| I | 202 (58.2%) | 25 (40.3%) |
|
| II | 123 (35.4%) | 29 (46.8%) |
|
| III | 22 (6.3%) | 5 (8.1%) |
|